Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.330 EUR | +3.74% | +6.39% | +14.04% |
Jan. 20 | Lhyfe: partnership with Atmen for traceability | CF |
Jan. 17 | Lhyfe: memorandum of understanding signed with Masdar | CF |
Company Valuation: Lhyfe
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 414.2 | 241.3 | 159.5 | 159.5 | - |
Change | - | -41.75% | -33.9% | 0% | - |
Enterprise Value (EV) 1 | 292 | 180.7 | 176.4 | 237.3 | 294 |
Change | - | -38.13% | -2.35% | 34.48% | 23.92% |
P/E ratio | -12.4x | -7.2x | -4.2x | -4.15x | -13.1x |
PBR | 2.39x | - | 2.47x | 4.79x | 6.4x |
PEG | -0.2x | - | -0.3x | -3.29x | 0.2x |
Capitalization / Revenue | 727x | 183x | 31.2x | 5.41x | 1.66x |
EV / Revenue | 512x | 137x | 34.5x | 8.05x | 3.06x |
EV / EBITDA | -17.2x | -6.43x | -6.08x | -11.5x | 76.5x |
EV / EBIT | -16.1x | -5.32x | -5.09x | -7.44x | -65.3x |
EV / FCF | -11x | -3.26x | -2.34x | -2.75x | -4.84x |
FCF Yield | -9.1% | -30.7% | -42.7% | -36.4% | -20.7% |
Dividend per Share 2 | - | - | - | - | - |
Rate of return | - | - | - | - | - |
EPS 2 | -0.7 | -0.7 | -0.7925 | -0.8025 | -0.2533 |
Distribution rate | - | - | - | - | - |
Net sales 1 | 0.57 | 1.317 | 5.114 | 29.46 | 96.24 |
EBITDA 1 | -17 | -28.1 | -29.04 | -20.57 | 3.844 |
EBIT 1 | -18.16 | -33.97 | -34.64 | -31.9 | -4.5 |
Net income 1 | -25.82 | -33.49 | -38.48 | -39 | -12.53 |
Net Debt 1 | -122.1 | -60.58 | 16.95 | 77.78 | 134.5 |
Reference price 2 | 8.650 | 5.040 | 3.330 | 3.330 | 3.330 |
Nbr of stocks (in thousands) | 47,879 | 47,868 | 47,891 | 47,891 | - |
Announcement Date | 3/22/23 | 3/28/24 | - | - | - |
P/E ratio, Detailed evolution
P/E ratio | EV / Sales | EV / EBITDA | Yield | Capi. ($) | ||
---|---|---|---|---|---|---|
-4.2x | 34.5x | -6.08x | - | 168M | ||
21.19x | 8.4x | 14.4x | +2.82% | 150B | ||
31.71x | 5.04x | 25.04x | +0.41% | 109B | ||
20.76x | 5.94x | 13.38x | +3.43% | 91.47B | ||
13.76x | 2.72x | 8.26x | +4.62% | 85.45B | ||
18.56x | 5.47x | 12.02x | +3.80% | 84.86B | ||
9.75x | 1.37x | 5.39x | +6.84% | 71.33B | ||
37.08x | 4.64x | 15.74x | +0.46% | 65.02B | ||
17.6x | 4.81x | 11.94x | +3.65% | 52.29B | ||
Average | 18.47x | 8.10x | 11.12x | +3.25% | 78.78B | |
Weighted average by Cap. | 21.57x | 5.22x | 13.91x | +3.11% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- LHYFE Stock
- Valuation Lhyfe